Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TSVT

2seventy bio (TSVT) Stock Price, News & Analysis

2seventy bio logo

About 2seventy bio Stock (NASDAQ:TSVT)

Advanced Chart

Key Stats

Today's Range
$5.00
$5.00
50-Day Range
$4.99
$5.00
52-Week Range
$2.29
$5.30
Volume
N/A
Average Volume
643,143 shs
Market Capitalization
$266.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

TSVT Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
See More Headlines

TSVT Stock Analysis - Frequently Asked Questions

2seventy bio, Inc. (NASDAQ:TSVT) announced its quarterly earnings data on Wednesday, May, 7th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.11. The business earned $22.94 million during the quarter, compared to analyst estimates of $13.96 million. 2seventy bio had a negative net margin of 207.25% and a negative trailing twelve-month return on equity of 53.65%.

Based on aggregate information from My MarketBeat watchlists, some other companies that 2seventy bio investors own include Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Home Depot (HD), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
5/07/2025
Today
7/17/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TSVT
CIK
1860782
Fax
N/A
Employees
440
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$217.57 million
Net Margins
-207.25%
Pretax Margin
-207.25%
Return on Equity
-53.65%
Return on Assets
-23.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.95
Quick Ratio
4.95

Sales & Book Value

Annual Sales
$48.37 million
Price / Sales
5.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.04 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
53,230,000
Free Float
47,874,000
Market Cap
$266.15 million
Optionable
Optionable
Beta
1.04
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TSVT) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners